BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 168379)

  • 1. Immune and non-immune macrophage resistance to the fibroma-myxoma virus complex.
    Tompkins WA; Rama Rao GV; Woan MC
    J Reticuloendothel Soc; 1975 Jul; 18(1):23-33. PubMed ID: 168379
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunohistology of malignant rabbit fibroma virus--a comparative study with rabbit myxoma virus.
    Strayer DS; Sell S
    J Natl Cancer Inst; 1983 Jul; 71(1):105-16. PubMed ID: 6306322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage immunity to vaccina virus: factors affecting macrophage immunity in vitro.
    Schultz RM; Woan MC; Tompkins WA
    J Reticuloendothel Soc; 1974 Jul; 16(1):37-47. PubMed ID: 4137839
    [No Abstract]   [Full Text] [Related]  

  • 4. Specific macrophage immunity to vaccinia virus: macrophage-virus interaction.
    Avila FR; Schultz RM; Tompkins WA
    Infect Immun; 1972 Jul; 6(1):9-16. PubMed ID: 4564156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serologically cross-reactive polypeptides in vaccinia, cowpox and Shope fibroma viruses.
    Ikuta K; Miyamoto H; Kato S
    J Gen Virol; 1979 Aug; 44(2):557-63. PubMed ID: 230296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-induced loss of class I MHC antigens from the surface of cells infected with myxoma virus and malignant rabbit fibroma virus.
    Boshkov LK; Macen JL; McFadden G
    J Immunol; 1992 Feb; 148(3):881-7. PubMed ID: 1309843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of plasmid vaccines to complex viruses: selected myxoma virus antigens as DNA vaccines were not protective.
    Adams MM; van Leeuwen BH; Kerr PJ
    Vaccine; 2004 Nov; 23(2):198-204. PubMed ID: 15531037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant rabbit fibroma virus: observations on the culture and histopathologic characteristics of a new virus-induced rabbit tumor.
    Strayer DS; Cabirac G; Sell S; Leibowitz JL
    J Natl Cancer Inst; 1983 Jul; 71(1):91-104. PubMed ID: 6306326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproduction of vaccinia virus (strain neurolapina) in rabbit blood leucocytes in vitro.
    Benda R; Cinátl J; Plaisner V
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(1):93-104. PubMed ID: 165236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed hypersensitivity in vaccinia-infected mice. II. Resistance of peritoneal macrophages against vaccinia infection.
    Ueda S; Nozima T
    Acta Virol; 1973 Jan; 17(1):41-9. PubMed ID: 4405395
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolation and characterization of a rabbit fibroma virus from a naturally occurring tumor.
    Kasza L
    Am J Vet Res; 1974 Jan; 35(1):87-9. PubMed ID: 4809601
    [No Abstract]   [Full Text] [Related]  

  • 12. Defective macrophage immunity in newborn rabbits with fibroma virus-induced tumors.
    Tompkins WA; RamaRao GV
    J Reticuloendothel Soc; 1978 Feb; 23(2):161-6. PubMed ID: 203693
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell surface antigens induced by poxviruses. I. Effects of antimetabolites on cell surface antigens.
    Miyamoto H; Kato S
    Biken J; 1971 Sep; 14(3):311-24. PubMed ID: 4109993
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on antigenic polypeptides induced by Shope fibroma virus.
    Ikuta K; Miyamoto H; Kato S
    Biken J; 1979 Jun; 22(2):75-80. PubMed ID: 231436
    [No Abstract]   [Full Text] [Related]  

  • 15. An immunohistologic study of Shope fibroma virus in rabbits: tumor rejection by cellular reaction in adults and progressive systemic reticuloendothelial infection in neonates.
    Sell S; Scott CB
    J Natl Cancer Inst; 1981 Feb; 66(2):363-73. PubMed ID: 6256578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor alpha, Shope fibroma growth factor, and vaccinia growth factor can replace myxoma growth factor in the induction of myxomatosis in rabbits.
    Opgenorth A; Nation N; Graham K; McFadden G
    Virology; 1993 Feb; 192(2):701-9. PubMed ID: 8380671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific secretion of polypeptides from cells infected with myxoma virus.
    Pennington TH; Carnegie GE; Alcock SR
    J Gen Virol; 1982 Jul; 61 (Pt l)():115-20. PubMed ID: 7119749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response in rabbit ovaries following infection of a recombinant myxoma virus expressing rabbit zona pellucida protein B.
    Gu W; Holland M; Janssens P; Seamark R; Kerr P
    Virology; 2004 Jan; 318(2):516-23. PubMed ID: 14972520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leporine acquired immune deficiency disease.
    Sell S; Strayer D; Skaletsky E; Corbeil L; Cabirac G; Leibowitz J
    Symp Fundam Cancer Res; 1986; 38():97-111. PubMed ID: 3018882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits.
    Mossman K; Nation P; Macen J; Garbutt M; Lucas A; McFadden G
    Virology; 1996 Jan; 215(1):17-30. PubMed ID: 8553583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.